Figure 2From: Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)28-Day all-cause mortality for PROWESS patients. Infusion refers to infusion period plus 1 calendar day after termination of infusion. DrotAA, drotrecogin alfa (activated); PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.Back to article page